9V2-32570-21744
1 vaccination
2 coded responses
16 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Extreme level of energy about four hours after injection, lasting a total of 10 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-12
- 2021-03-20
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2022-03-07
Survey response — 12 months, dose 1MedDRA: Amnesia, Fatigue — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue and memory lossMedDRA releases: 2024-11 · check-in free text available
-
2022-03-07
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Janssen/Johnson & Johnson |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Extreme level of energy about four hours after injection, lasting a total of 10 hours.
Release 11 — 12 months, dose 1
Symptoms: Fatigue and memory loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amnesia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release